CD1dhiCD5+ B cells expanded by GM-CSF in vivo suppress experimental autoimmune myasthenia gravis

Journal of Immunology

Volumn 193, Issue 6, 2014, Pages 2669-2677

  Sheng, Jian Rong ^a   Quan, Songhua ^a   Soliven, Betty ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD1D ANTIGEN; CD5 ANTIGEN; CELL MARKER; CHOLINERGIC RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; CD1D ANTIGEN, MOUSE; CD5 PROTEIN, MOUSE; IL10 PROTEIN, MOUSE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL PROLIFERATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOTHERAPY; METABOLISM; PROCEDURES;

ANIMALS; ANTIGENS, CD1D; ANTIGENS, CD5; B-LYMPHOCYTES; CELL PROLIFERATION; DENDRITIC CELLS; DOWN-REGULATION; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNE TOLERANCE; IMMUNOTHERAPY; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL; RECEPTORS, CHOLINERGIC; T-LYMPHOCYTES, REGULATORY;

EID: 84921685587     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1303397     Document Type: Article

References (72)

1. Le Panse, R., and S. Berrih-Aknin. 2013. Autoimmune myasthenia gravis: autoantibody mechanisms and new developments on immune regulation. Curr. Opin. Neurol. 26: 569-576.
2. Meriggioli, M. N., and D. B. Sanders. 2009. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol. 8: 475-490.
3. Wu, B., E. Goluszko, R. Huda, E. Tüzün, and P. Christadoss. 2013. Experimental autoimmune myasthenia gravis in the mouse. Curr. Protoc. Immunol. Chapter 15: Unit 15.8.
4. Christadoss, P., M. Poussin, and C. Deng. 2000. Animal models of myasthenia gravis. Clin. Immunol. 94: 75-87.
5. Cossins, J., K. Belaya, K. Zoltowska, I. Koneczny, S. Maxwell, L. Jacobson, M. I. Leite, P. Waters, A. Vincent, and D. Beeson. 2012. The search for new antigenic targets in myasthenia gravis. Ann. N. Y. Acad. Sci. 1275: 123-128.
6. Vincent, A., M. I. Leite, M. E. Farrugia, S. Jacob, S. Viegas, H. Shiraishi, O. Benveniste, B. P. Morgan, D. Hilton-Jones, J. Newsom-Davis, et al. 2008. Myasthenia gravis seronegative for acetylcholine receptor antibodies. Ann. N. Y. Acad. Sci. 1132: 84-92.
7. Vincent, A. 2006. Immunology of disorders of neuromuscular transmission. Acta Neurol. Scand. Suppl. 183: 1-7.
8. Sheng, J. R., L. C. Li, B. B. Ganesh, B. S. Prabhakar, and M. N. Meriggioli. 2008. Regulatory T cells induced by GM-CSF suppress ongoing experimental myasthenia gravis. Clin. Immunol. 128: 172-180.
9. Sheng, J. R., L. Li, B. B. Ganesh, C. Vasu, B. S. Prabhakar, and M. N. Meriggioli. 2006. Suppression of experimental autoimmune myasthenia gravis by granulocytemacrophage colony-stimulating factor is associated with an expansion of FoxP3+ regulatory T cells. J. Immunol. 177: 5296-5306.
10. Meriggioli, M. N., J. R. Sheng, L. Li, and B. S. Prabhakar. 2008. Strategies for treating autoimmunity: novel insights from experimental myasthenia gravis. Ann. N. Y. Acad. Sci. 1132: 276-282.
11. Sheng, J. R., T. Muthusamy, B. S. Prabhakar, and M. N. Meriggioli. 2011. GMCSF-induced regulatory T cells selectively inhibit anti-acetylcholine receptorspecific immune responses in experimental myasthenia gravis. J. Neuroimmunol. 240-241: 65-73.
12. O'Keeffe, M., H. Hochrein, D. Vremec, J. Pooley, R. Evans, S. Woulfe, and K. Shortman. 2002. Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice. Blood 99: 2122-2130.
13. Hamilton, J. A., and A. Achuthan. 2013. Colony stimulating factors and myeloid cell biology in health and disease. Trends Immunol. 34: 81-89.
14. Parmiani, G., C. Castelli, L. Pilla, M. Santinami, M. P. Colombo, and L. Rivoltini. 2007. Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients. Ann. Oncol. 18: 226-232.
15. Pulendran, B., J. Banchereau, S. Burkeholder, E. Kraus, E. Guinet, C. Chalouni, D. Caron, C. Maliszewski, J. Davoust, J. Fay, and K. Palucka. 2000. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J. Immunol. 165: 566-572.
16. Ponomarev, E. D., L. P. Shriver, K. Maresz, J. Pedras-Vasconcelos, D. Verthelyi, and B. N. Dittel. 2007. GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis. J. Immunol. 178: 39-48.
17. McQualter, J. L., R. Darwiche, C. Ewing, M. Onuki, T. W. Kay, J. A. Hamilton, H. H. Reid, and C. C. Bernard. 2001. Granulocyte macrophage colonystimulating factor: a new putative therapeutic target in multiple sclerosis. J. Exp. Med. 194: 873-882.
18. Marusic, S., J. S. Miyashiro, J. Douhan, III, R. F. Konz, D. Xuan, J. W. Pelker, V. Ling, J. P. Leonard, and K. A. Jacobs. 2002. Local delivery of granulocyte macrophage colony-stimulating factor by retrovirally transduced antigen-specific T cells leads to severe, chronic experimental autoimmune encephalomyelitis in mice. Neurosci. Lett. 332: 185-189.
19. Wolf, S. D., B. N. Dittel, F. Hardardottir, and C. A. Janeway, Jr. 1996. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184: 2271-2278.
20. DiLillo, D. J., T. Matsushita, and T. F. Tedder. 2010. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann. N. Y. Acad. Sci. 1183: 38-57.
21. Mizoguchi, A., and A. K. Bhan. 2006. A case for regulatory B cells. J. Immunol. 176: 705-710.
22. Mauri, C., and A. Bosma. 2012. Immune regulatory function of B cells. Annu. Rev. Immunol. 30: 221-241.
23. Matsushita, T. 2010. [Regulatory B cell and autoimmune disease]. Nihon Rinsho Meneki Gakkai Kaishi 33: 234-241.
24. Lemoine, S., A. Morva, P. Youinou, and C. Jamin. 2009. Regulatory B cells in autoimmune diseases: how do they work? Ann. N. Y. Acad. Sci. 1173: 260-267.
25. Lehmann-Horn, K., H. C. Kronsbein, and M. S. Weber. 2013. Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges. Ther. Adv. Neurol. Disord. 6: 161-173.
26. Kalampokis, I., A. Yoshizaki, and T. F. Tedder. 2013. IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res. Ther. 15(Suppl. 1): S1.
27. Jensen, F., D. Muzzio, R. Soldati, S. Fest, and A. C. Zenclussen. 2013. Regulatory B10 cells restore pregnancy tolerance in a mouse model. Biol Reprod. 89: 90.
28. Giannoukakis, N., and M. Trucco. 2012. A role for tolerogenic dendritic cellinduced B-regulatory cells in type 1 diabetes mellitus. Curr. Opin. Endocrinol. Diabetes Obes. 19: 279-287.
29. Evans, J. G., K. A. Chavez-Rueda, A. Eddaoudi, A. Meyer-Bahlburg, D. J. Rawlings, M. R. Ehrenstein, and C. Mauri. 2007. Novel suppressive function of transitional 2 B cells in experimental arthritis. J. Immunol. 178: 7868-7878.
30. Yanaba, K., J. D. Bouaziz, K. M. Haas, J. C. Poe, M. Fujimoto, and T. F. Tedder. 2008. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28: 639-650.
31. Matsushita, T., K. Yanaba, J. D. Bouaziz, M. Fujimoto, and T. F. Tedder. 2008. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 118: 3420-3430.
32. Matsushita, T., and T. F. Tedder. 2011. Identifying regulatory B cells (B10 cells) that produce IL-10 in mice. Methods Mol. Biol. 677: 99-111.
33. Mauri, C. 2010. Regulation of immunity and autoimmunity by B cells. Curr. Opin. Immunol. 22: 761-767.
34. Poe, J. C., S. H. Smith, K. M. Haas, K. Yanaba, T. Tsubata, T. Matsushita, and T. F. Tedder. 2011. Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice. PLoS ONE 6: e22464.
35. Yanaba, K., J. D. Bouaziz, T. Matsushita, C. M. Magro, E. W. St Clair, and T. F. Tedder. 2008. B-lymphocyte contributions to human autoimmune disease. Immunol. Rev. 223: 284-299.
36. Yang, X., J. Yang, Y. Chu, J. Wang, M. Guan, X. Zhu, Y. Xue, and H. Zou. 2013. T follicular helper cells mediate expansion of regulatory B cells via IL-21 in Lupus-prone MRL/lpr mice. PLoS ONE 8: e62855.
37. Yoshizaki, A., T. Miyagaki, D. J. DiLillo, T. Matsushita, M. Horikawa, E. I. Kountikov, R. Spolski, J. C. Poe, W. J. Leonard, and T. F. Tedder. 2012. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 491: 264-268.
38. Mariño, E., and S. T. Grey. 2012. B cells as effectors and regulators of autoimmunity. Autoimmunity 45: 377-387.
39. Mariño, E., M. Batten, J. Groom, S. Walters, D. Liuwantara, F. Mackay, and S. T. Grey. 2008. Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells. Diabetes 57: 395-404.
40. Rolf, J., V. Motta, N. Duarte, M. Lundholm, E. Berntman, M. L. Bergman, L. Sorokin, S. L. Cardell, and D. Holmberg. 2005. The enlarged population of marginal zone/CD1d(high) B lymphocytes in nonobese diabetic mice maps to diabetes susceptibility region Idd11. J. Immunol. 174: 4821-4827.
41. Watanabe, R., N. Ishiura, H. Nakashima, Y. Kuwano, H. Okochi, K. Tamaki, S. Sato, T. F. Tedder, and M. Fujimoto. 2010. Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J. Immunol. 184: 4801-4809.
42. Yanaba, K., J. D. Bouaziz, T. Matsushita, T. Tsubata, and T. F. Tedder. 2009. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J. Immunol. 182: 7459-7472.
43. Yang, M., K. Rui, S. Wang, and L. Lu. 2013. Regulatory B cells in autoimmune diseases. Cell. Mol. Immunol. 10: 122-132.
44. Yang, M., L. Sun, S. Wang, K. H. Ko, H. Xu, B. J. Zheng, X. Cao, and L. Lu. 2010. Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells. J. Immunol. 184: 3321-3325.
45. Mauri, C., D. Gray, N. Mushtaq, and M. Londei. 2003. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197: 489-501.
46. Mauri, C., and P. A. Blair. 2010. Regulatory B cells in autoimmunity: developments and controversies. Nat. Rev. Rheumatol. 6: 636-643.
47. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-950.
48. Shen, P., V. Lampropoulou, U. Stervbo, E. Hilgenberg, S. Ries, A. Mecqinion, and S. Fillatreau. 2013. Intrinsic Toll-like receptor signalling drives regulatory function in B cells. Front. Biosci. (Elite Ed.) 5: 78-86 (Elite Ed).
49. Bettelli, E., M. P. Das, E. D. Howard, H. L. Weiner, R. A. Sobel, and V. K. Kuchroo. 1998. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161: 3299-3306.
50. Ding, L., P. S. Linsley, L. Y. Huang, R. N. Germain, and E. M. Shevach. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151: 1224-1234.
51. Fiorentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146: 3444-3451.
52. Sanjabi, S., L. A. Zenewicz, M. Kamanaka, and R. A. Flavell. 2009. Antiinflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. Curr. Opin. Pharmacol. 9: 447-453.
53. Defrance, T., B. Vanbervliet, F. Brière, I. Durand, F. Rousset, and J. Banchereau. 1992. Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J. Exp. Med. 175: 671-682.
54. Rousset, F., E. Garcia, T. Defrance, C. Péronne, N. Vezzio, D. H. Hsu, R. Kastelein, K. W. Moore, and J. Banchereau. 1992. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 89: 1890-1893.
55. Bai, X. F., J. Zhu, G. X. Zhang, G. Kaponides, B. Höjeberg, P. H. van der Meide, and H. Link. 1997. IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1-type immune responses. Clin. Immunol. Immunopathol. 83: 117-126.
56. Kühn, R., J. Löhler, D. Rennick, K. Rajewsky, and W. Müller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274.
57. Matsushita, T., M. Horikawa, Y. Iwata, and T. F. Tedder. 2010. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J. Immunol. 185: 2240-2252.
58. Maseda, D., K. M. Candando, S. H. Smith, I. Kalampokis, C. T. Weaver, S. E. Plevy, J. C. Poe, and T. F. Tedder. 2013. Peritoneal cavity regulatory B cells (B10 cells) modulate IFN-γ+CD4+ T cell numbers during colitis development in mice. J. Immunol. 191: 2780-2795.
59. Yanaba, K., M. Kamata, N. Ishiura, S. Shibata, Y. Asano, Y. Tada, M. Sugaya, T. Kadono, T. F. Tedder, and S. Sato. 2013. Regulatory B cells suppress imiquimod-induced, psoriasis-like skin inflammation. J. Leukoc. Biol. 94: 563-573.
60. Le Huu, D., T. Matsushita, G. Jin, Y. Hamaguchi, M. Hasegawa, K. Takehara, T. F. Tedder, and M. Fujimoto. 2013. Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease. Blood 121: 3274-3283.
61. Horikawa, M., E. T. Weimer, D. J. DiLillo, G. M. Venturi, R. Spolski, W. J. Leonard, M. T. Heise, and T. F. Tedder. 2013. Regulatory B cell (B10 Cell) expansion during Listeria infection governs innate and cellular immune responses in mice. J. Immunol. 190: 1158-1168.
62. Zhang, G. X., B. G. Xiao, L. Y. Yu, P. H. van der Meide, and H. Link. 2001. Interleukin 10 aggravates experimental autoimmune myasthenia gravis through inducing Th2 and B cell responses to AChR. J. Neuroimmunol. 113: 10-18.
63. Poussin, M. A., C. L. Fuller, E. Goluszko, V. E. Reyes, V. L. Braciale, and P. Christadoss. 2003. Suppressed clinical experimental autoimmune myasthenia gravis in bm12 mice is linked to reduced intracellular calcium mobilization and IL-10 and IFN-gamma release by acetylcholine receptor-specific T cells. J. Neuroimmunol. 134: 104-110.
64. Wei, B., P. Velazquez, O. Turovskaya, K. Spricher, R. Aranda, M. Kronenberg, L. Birnbaumer, and J. Braun. 2005. Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets. Proc. Natl. Acad. Sci. USA 102: 2010-2015.
65. Mann, M. K., K. Maresz, L. P. Shriver, Y. Tan, and B. N. Dittel. 2007. B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J. Immunol. 178: 3447-3456.
66. Gray, M., K. Miles, D. Salter, D. Gray, and J. Savill. 2007. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc. Natl. Acad. Sci. USA 104: 14080-14085.
67. Amu, S., S. P. Saunders, M. Kronenberg, N. E. Mangan, A. Atzberger, and P. G. Fallon. 2010. Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J. Allergy Clin. Immunol. 125: 1114-1124.e8.
68. + regulatory T cells proceeds normally in the absence of B cells during EAE. Eur. J. Immunol. 42: 1164-1173.
69. Bhattacharya, P., A. Gopisetty, B. B. Ganesh, J. R. Sheng, and B. S. Prabhakar. 2011. GM-CSF-induced, bone-marrow-derived dendritic cells can expand natural Tregs and induce adaptive Tregs by different mechanisms. J. Leukoc. Biol. 89: 235-249.
70. Rafei, M., J. Hsieh, S. Zehntner, M. Li, K. Forner, E. Birman, M. N. Boivin, Y. K. Young, C. Perreault, and J. Galipeau. 2009. A granulocyte-macrophage colony-stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties. Nat. Med. 15: 1038-1045.
71. Sun, F., S. S. Ladha, L. Yang, Q. Liu, S. X. Shi, N. Su, R. Bomprezzi, and F. D. Shi. 2014. Interleukin-10 producing-B cells and their association with responsiveness to rituximab in myasthenia gravis. Muscle Nerve 49: 487-494.
72. Rowin, J., M. Thiruppathi, E. Arhebamen, J. Sheng, B. S. Prabhakar, and M. N. Meriggioli. 2012. Granulocyte macrophage colony-stimulating factor treatment of a patient in myasthenic crisis: effects on regulatory T cells. Muscle Nerve 46: 449-453.